To www.iknl.nl
- Palliative care > Delirium
Guideline Notification E-mail guideline Homepage Oncoline
----------

Last changed: 2010-05-10, Version: 3.0, Justification: Redactie Palliatieve Zorg: richtlijnen voor de praktijk, Type: nation-wide guideline

References

1 - Agar M (2008)
Agar M, Lawlor P. Delirium in cancer patients: a focus on treatment-induced psychopathology. Current Opinion in Oncology 2008; 20: 360-366.
 
2 - American Psychiatric Asociation (1999)
American Psychiatric Asociation. Practice guideline for the treatment of patients with delirium. American Journal of Psychiatry 1999; 156 (Suppl. 5): 1-20.
 
3 - Brajtman S (2003)
Brajtman S. The impact on the family of terminal restlessness and its management. Palliative Medicine 2003; 17: 454-60.
 
4 - Breitbart W (2002)
Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002; 43: 183-194.
 
5 - Breitbart W (1996)
Breitbart W, Marotta R, Platt MM et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry 1996; 153: 231-237.
 
6 - Breitbart W (2002)
Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43: 175-182.
 
7 - Bruera E (2009)
Bruera E, Bush SH, Willey J et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 2009; 115: 2004-2012.
 
8 - Bruera E (1992)
Bruera E, Miller L, McCallion J et al. Cognitive failure in patients with terminal cancer : a prospective study. Journal of Pain and Symptom Management 1992; 7: 192-195.
 
9 - Bruera E (2005)
Bruera E, Sala M, Rico MA et al. Effects of Parenteral Hydration in Terminally Ill Cancer Patients: A Preliminary Study. Journal of Clinical Oncology 2005; 23: 2366-2371.
 
10 - Caraceni A (2000)
Caraceni A, Nanni O, Maltoni M et al. Impact of delirium on the short term prognosis of advanced cancer patients. Cancer 2000; 89: 1145-1149.
 
11 - Caraceni A (2009)
Caraceni A, Simonetti F. Palliating delirium in patients with cancer. Lancet Oncology 2009; 10: 164-172.
 
12 - Casarett DJ (2001)
Casarett DJ, Inouye SK. Diagnosis and management of delirium near the end of life. Annals of Internal Medicine 2001; 135: 32-40.
 
13 - CBO (Kwaliteitsorgaan voor de Gezondheidszorg) (2005)
CBO (Kwaliteitsorgaan voor de Gezondheidszorg). CBO-richtlijn Delirium, 2005.
 
14 - Centeno C (2004)
Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliative Medicine 2004; 18: 184-194.
 
15 - Cerchietti L (2000)
Cerchietti L, Navigante A, Sauri A et al. Hypodermoclysis for control of dehydration in terminal-stage cancer. Journal of Palliative Nursing 2000; 6: 370-374.
 
16 - Cole MG (1999)
Cole MG. Delirium: effectiveness of systematic interventions. Dementia and Geriatric Cognitive Disorders 1999; 10: 406-411.
 
17 - Del Fabbro E (2006)
Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care – part III: Dyspnea and delirium. Journal of Palliative Medicine 2006; 9: 422-436.
 
18 - Fainsinger RL (1997)
Fainsinger RL, Bruera E. When to treat dehydration in a terminally ill patient? Supportive Care in Cancer 1997; 5: 205-211.
 
19 - Gagnon P (2002)
Gagnon P, Charbonneau C, Allard P et al. Delirium in advanced cancer : a psychoeducational intervention for family caregivers. Journal of Palliative Care 2002; 18: 253-261.
 
20 - Gagnon PR (2008)
Gagnon PR. Treatment of delirium in supportive and palliative care. Current Opinion in Supportive and Palliative Care 2008; 2: 60-66.
 
21 - Gemert van LA (2007)
Gemert van LA, Schuurmans MJ. The Neecham Confusion Scale and the Delirium Observation Screening Scale: capacity to discriminate and ease of use in clinical practice. BMC Nursing 2007; 6: 3.
 
22 - Han CS (2004)
Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45: 297-301.
 
23 - Inouye SK (1999)
Inouye SK, Bogardus ST, Charpentier PA et al. A multicomponent intervention to prevent delirium in hospitalized older patients. New England Journal of Medicine 1999, 340: 669-676.
 
24 - Inouye SK (1999)
Inouye SK. Predisposing and precipitating factors for delirium in hospitalized older patients. Dementia and Geriatric Cognitive Disorders 1999; 10: 393-400.
 
25 - Inouye SK (2006)
Inouye SK. Delirium in older persons. New England Journal of Medicine 2006; 354: 1157-1165.
 
26 - Jacobs WM (1998)
Jacobs WM, Thiesbrummel AW, Zylicz Z. Behandeling van onrust bij stervenden: meer dan sederen alleen. Nederlands Tijdschrift voor Geneeskunde 1998; 142: 433-436.
 
27 - Jackson KC (2004)
Jackson KC, Lipman AG. Drug therapy for delirium in terminally ill patients. Cochrane Database of Systematic Reviews 2004; 2: CD004770.
 
28 - Kalisvaart CJ (2004)
Kalisvaart CJ, Boelaarts L, Jonghe de JFM et al. Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine. Nederlands Tijdschrift voor Geneeskunde 2004; 148: 1501-1504.
 
29 - Kehl KA (2004)
Kehl KA. Treatment of terminal reslessness: a review of the evidence. Journal of Pain and Palliative Care Pharmacotherapy 2004; 18: 5-30.
 
30 - Kim KS (2001)
Kim KS, Pae CU, Chae JH et al. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry and Clinical Neurosciences 2001; 55: 515-519.
 
31 - Kim KY (2003)
Kim KY, Bader GM, Kotlyar V et al. Treatment of delirium in older adults with quetiapine. Journal of Geriatric Psychiatry and Neurology 2003; 16: 29-31.
 
32 - Lacasse H (2006)
Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. The Annals of Pharmacotherapy 2006; 40: 1966-1973.
 
33 - Lawlor PG (2000)
Lawlor PG, Gagnon B, Mancini IL et al. Occurrence, causes and outcome of delirium in patients with advanced cancer: a prospective study. Archives of Internal Medicine 2000; 160: 786-794.
 
34 - Lawlor PG (2002)
Lawlor PG. Delirium and dehydration: some fluid for thought? Supportive Care in Cancer 2002; 10: 445-454.
 
35 - Leonard M (2008)
Leonard M, Raju B, Conroy M et al. Reversibility of delirium in terminally ill patients and predictors of mortality. Palliative Medicine 2008; 22: 848-854.
 
36 - Leonard M (2008)
Leonard M, Agar M, Mason C et al. Delirium issues in palliative care settings. Journal of Psychosomatic Research 2008; 65: 289-298.
 
37 - Ligt van der W (2003)
Ligt van der W, Koelewijnen M, Zylicz Z. Delirium door pijnbestrijding in de terminale levensfase kan worden vermeden. Nederlands Tijdschrift voor Geneeskunde 2003; 147: 185-188.
 
38 - Lonergan E (2007)
Lonergan E, Britton AM, Luxenberg J et al. Antipsychotics for delirium. Cochrane Database of Systematic Reviews 2007; 2: CD005594.
 
39 - Lundström M (2005)
Lundström M, Edlund A, Karlsson S et al. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. Journal of the American Geriatrics Society 2005; 53: 622-628.
 
40 - Mast van der RC (2005)
Mast van der RC, Huyseen FJ, Rosier PF. Richtlijn ‘delirium’. Nederlands Tijdschrift voor Geneeskunde 2005; 149: 1027-1032.
 
41 - Mazzocato C (2000)
Mazzocato C, Stiefel F, Buclin T et al. Psychopharmacology in supportive care of cancer: a review for the clinician: II. Neuroleptics. Supportive Care in Cancer 2000; 8: 89-97.
 
42 - McCusker J (2002)
McCusker J, Cole M, Abrahamowicz M et al. Delirium predicts 12-month mortality. Archives of Internal Medicine 2002; 162: 457-463.
 
43 - Meagher DJ (2001)
Meagher DJ. Delirium: optimising management. British Medical Journal 2001; 322: 144-149.
 
44 - Mellick EJ (2002)
Mellick EJ, Vries de OJ. Geneesmiddelen en ouderen: het delirium. Geneesmiddelenbulletin 2002; 36: 73-78.
 
45 - Metitieri T (2000)
Metitieri T, Bianchetti A, Trabucchi M. Delirium as a predictor of survival in older patients with advanced cancer. Archives of Internal Medicine 2000; 160: 2866-2868.
 
46 - Meyersen BJ (2004)
Meyersen BJ, Ojen van RL. De behandeling met methylfenidaat van demoralisatie, apathie en hypoactief delier met een somatische ziekte. Nederlands Tijdschrift voor Geneeskunde 2004; 148: 1738-1741.
 
47 - Milisen K (2005)
Milisen K, Lemiengre J, Braes T et al. Multicomponent intervention strategies for managing delirium in hospitalized older people: systematic review. Journal of Advanced Nursing 2005; 52: 79-90.
 
48 - Mittal D (2004)
Mittal D, Jimerson NA, Neeley EP et al. Risperidone in the treatment of delirium: results from a prospective open-label trial. Journal of Clinical Psychiatry 2004; 65: 662-667.
 
49 - Moretti R (2004)
Moretti R, Torre P, Antonello RM et al. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients. American Journal of Alzheimer’s Disease and Other Dementias 2004; 19: 333-339.
 
50 - Morita T (2007)
Morita T, Akechi T, Ikenaga M et al. Terminal delirium: recommendations from bereaved families’ experiences. Journal of Pain and Symptom Management 2007; 34: 579-589.
 
51 - Morita T (2003)
Morita T, Tei Y, Inoue S. Agitated terminal delirium and association with partial opioid substitution and hydration. Journal of Palliative Medicine 2003: 557-563.
 
52 - Morita T (2001)
Morita T, Tei Y, Tsunoda J et al. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. Journal of Pain and Symptom Management 2001; 22: 997-1006.
 
53 - Namba M (2007)
Namba M, Morita T, Imura C et al. Terminal delirium : families’ experience. Palliative Medicine 2007; 21: 587-594.
 
54 - Nowels DE (2002)
Nowels DE, Bublitz C, Kassner CT et al. Estimation of confusion prevalence in hospice patients. Journal of Palliative Medicine 2002: 687-695.
 
55 - O’Malley G (2008)
O’Malley G, Leonard M, Meagher D, O’Keeffe ST. The delirium experience: a review. Journal of Psychosomatic Research 2008; 65: 223-228.
 
56 - Overshott R (2008)
Overshott R, Karim S, Burns A. Cholinesterase inhibitors for delirium. Cochrane Database of Systematic Reviews 2008; 23: CD005317.
 
57 - Passik SD (1999)
Passik SD, Cooper M. Complicated delirium in a cancer patient successfully treated with olanzapine. Journal of Pain and Symptom Management 1999 Mar;17:219-223.
 
58 - Sasaki Y (2003)
Sasaki Y, Matsuyama T, Inoue S et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. Journal of Clinical Psychiatry 2003; 64: 1316-1321.
 
59 - Schuurmans MJ (2003)
Schuurmans MJ, Shortridge-Baggett LM, Duursma SA. The Delirium Observation Screening Scale: a screening instrument for delirium. Research and Theory for Nursing Practice 2003: 17: 31-50.
 
60 - Sharma ND (1998)
Sharma ND, Rosman HS, Padhi ID et al. Torsades de Pointes associated with intravenous haloperidol in critically ill patients. American Journal of Cardiology 1998; 81: 238-240.
 
61 - Siddiqi N (2008)
Siddiqi N, Young J, Cheater FM et al. Educating staff working in long-term care about delirium: the Trojan horse for improving quality of care? Journal of Psychosomatic Research 2008 Sep;65:261-266. Review.
 
62 - Spiller JA (2006)
Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliative Medicine 2006; 20: 17-23.
 
63 - Tabet N (2005)
Tabet N, Hudson S, Sweeney V et al. An educational intervention can prevent delirium on acute medical wards. Age and Ageing 2005; 34: 152-156.
 
64 - Torres R (2001)
Torres R, Mittal D, Kennedy R. Use of quetiapine in delirium: case reports. Psychosomatics 2001; 42: 347-349.
 
65 - Vella-Brincat J (2004)
Vella-Brincat J, MacLeod AD. Haloperidol in palliative care. Palliative Medicine 2004; 18: 195-201.
 
66 - Weele van der GM (2003)
Weele van der GM, Olde Rikkert MG, Eizenga WH et al. Samenvatting van de standaard ‘Delier bij ouderen’ van het Nederlands Huisartsen Genootschap. Nederlands Tijdschrift voor Geneeskunde 2003; 147: 965-969 (Reacties hierop van Izaks GJ en Mast van der RC: Nederlands Tijdschrift voor Geneeskunde 2003; 147: 949-955).
 
67 - White C (2007)
White C, McCann MA, Jackson N. First do no harm… Terminal restlessness or drug-induced delirium. Journal of Palliative Medicine 2007; 10: 345-351.
 
68 - Wilde AAM (2002)
Wilde AAM. Geneesmiddelen en het lange QT-interval. Geneesmiddelenbulletin 2002; 36: 27-32.